These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 34893417)
1. Impact of serum uric acid levels on cardiovascular events and quality of life in patients with chronic coronary syndromes: Insights from a contemporary, prospective, nationwide registry. De Luca L; Gulizia MM; Gabrielli D; Meessen J; Mattei L; D'Urbano M; Colivicchi F; Temporelli PL; Borghi C; Desideri G; Nutr Metab Cardiovasc Dis; 2022 Feb; 32(2):393-401. PubMed ID: 34893417 [TBL] [Abstract][Full Text] [Related]
2. Impact of history of depression on 1-year outcomes in patients with chronic coronary syndromes: An analysis of a contemporary, prospective, nationwide registry. De Luca L; Temporelli PL; Amico AF; Gonzini L; Uguccioni M; Varani E; Brunetti ND; Colivicchi F; Gabrielli D; Gulizia MM Int J Cardiol; 2021 May; 331():273-280. PubMed ID: 33422564 [TBL] [Abstract][Full Text] [Related]
3. Impact of Elevated Serum Uric Acid Level on Target Lesion Revascularization After Percutaneous Coronary Intervention for Chronic Total Occlusion. Okuya Y; Saito Y; Takahashi T; Kishi K Am J Cardiol; 2019 Dec; 124(12):1827-1832. PubMed ID: 31653354 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout: A Retrospective Analysis Using Electronic Medical Record Data. Essex MN; Hopps M; Bienen EJ; Udall M; Mardekian J; Makinson GT J Clin Rheumatol; 2017 Apr; 23(3):160-166. PubMed ID: 28248798 [TBL] [Abstract][Full Text] [Related]
14. Impact of uric acid on immature platelet fraction in patients undergoing percutaneous coronary intervention. Nardin M; Verdoia M; Negro F; Tonon F; De Luca G Thromb Res; 2021 Feb; 198():171-181. PubMed ID: 33348191 [TBL] [Abstract][Full Text] [Related]
15. Serum uric acid, influence of sacubitril-valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF. Selvaraj S; Claggett BL; Pfeffer MA; Desai AS; Mc Causland FR; McGrath MM; Anand IS; van Veldhuisen DJ; Kober L; Janssens S; Cleland JGF; Pieske B; Rouleau JL; Zile MR; Shi VC; Lefkowitz MP; McMurray JJV; Solomon SD Eur J Heart Fail; 2020 Nov; 22(11):2093-2101. PubMed ID: 32840930 [TBL] [Abstract][Full Text] [Related]
16. Serum uric acid as a clinically useful nutritional marker and predictor of outcome in maintenance hemodialysis patients. Beberashvili I; Sinuani I; Azar A; Shapiro G; Feldman L; Stav K; Sandbank J; Averbukh Z Nutrition; 2015 Jan; 31(1):138-47. PubMed ID: 25466658 [TBL] [Abstract][Full Text] [Related]
17. Hyperuricemia Predicts Adverse Outcomes After Myocardial Infarction With Non-obstructive Coronary Arteries. Mohammed AQ; Abdu FA; Liu L; Zhang W; Yin G; Xu Y; Che W Front Med (Lausanne); 2021; 8():716840. PubMed ID: 34568374 [No Abstract] [Full Text] [Related]
18. Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry. Ambrosio G; Leiro MGC; Lund LH; Coiro S; Cardona A; Filippatos G; Ferrari R; Piepoli MF; Coats AJS; Anker SD; Laroche C; Almenar-Bonet L; Poder P; Valero DB; Frisinghelli A; Maggioni AP Eur J Intern Med; 2021 Jul; 89():65-75. PubMed ID: 33896684 [TBL] [Abstract][Full Text] [Related]
19. Hyperuricemia predicts increased cardiovascular events in patients with chronic coronary syndrome after percutaneous coronary intervention: A nationwide cohort study from Japan. Akashi N; Kuwabara M; Matoba T; Kohro T; Oba Y; Kabutoya T; Imai Y; Kario K; Kiyosue A; Mizuno Y; Nochioka K; Nakayama M; Iwai T; Nakao Y; Iwanaga Y; Miyamoto Y; Ishii M; Nakamura T; Tsujita K; Sato H; Fujita H; Nagai R Front Cardiovasc Med; 2022; 9():1062894. PubMed ID: 36704454 [TBL] [Abstract][Full Text] [Related]